In public health, a 16-year delay in diagnosing a treatable condition is a systemic failure. Yet, this is the stark reality facing countless women and girls across the United States living with undiagnosed bleeding disorders.
To dismantle these deeply entrenched clinical and diagnostic barriers, federal lawmakers have officially introduced the Fostering Effective Diagnosis and Treatment for Underserved Populations with Bleeding Disorders Act of 2026 (also known as the FED UP with Bleeding Disorders Act). With key bipartisan backing—notably co-sponsored by South Carolina’s own Representative Joe Wilson (R-SC-02)—this legislation marks a pivotal shift toward health equity in specialized medicine.
The Healthcare Deficit by the Numbers
The legislative findings driving this bill highlight a profound gap in our current care delivery models:
The Undiagnosed Population: Current estimates indicate up to 1% of women in the U.S. have a bleeding disorder, a significant portion of whom remain entirely unaware of their status.
The Specialized Care Advantage: Mortality and hospitalization rates for bleeding complications are 40% lower among patients who receive care within dedicated Hemophilia Treatment Centers (HTCs) compared to those who do not. Without a timely diagnosis, women are effectively locked out of this life-saving network.
The Economic and Clinical Toll: Chronic mismanagement of symptoms like heavy menstrual bleeding leads to severe clinical interventions—including unnecessary hysterectomies that compromise fertility. Nationally, this failure in early intervention incurs a staggering $1 billion in direct annual healthcare costs and $12 billion in indirect economic losses.
A Coordinated Federal Strategy
The FED UP Act does not just call for awareness; it mandates structural accountability across federal health infrastructure. The bill targets systemic reform through two primary mechanisms:
Interagency Alignment: The Secretary of Health and Human Services (HHS) will head a comprehensive, multi-agency review to update federal strategic plans, research inclusion, and provider training. This initiative will bridge clinical silos by aligning data and resources across the CDC, NIH, HRSA, CMS, and FDA.
Targeted Provider Education: Moving beyond general public service announcements, the bill authorizes $10,000,000 annually (from fiscal years 2027 through 2031) for an evidence-based national campaign. This campaign is specifically designed to equip frontline clinicians—including primary care physicians, pediatricians, school nurses, and OB/GYNs—with the tools necessary to recognize early symptoms and accelerate HTC referrals.
Elevating the Palmetto State’s Voice
This legislative milestone is deeply connected to local advocacy efforts. South Carolina healthcare advocates and clinicians have long witnessed the downstream complications of delayed hematological care, particularly in our rural and underserved medical communities. The bipartisan leadership on this bill underscores a growing recognition that diagnostic equity is a critical component of achieving the nation’s baseline public health objectives, such as those outlined in the HHS Healthy People 2030 initiative.
As the FED UP Act advances through the United States Congress, the Palmetto Health Collective will continue to track its progress and monitor how these upcoming federal grant opportunities can be leveraged to improve rural health infrastructure right here in South Carolina.
Explore the Legislation: To review the precise statutory framework and interagency mandates, you can read the full legislative text directly through Representative Julie Johnson’s Legislative Portal. To see how national healthcare organizations are reacting to this shifting policy landscape, read the community briefing via the National Bleeding Disorders Foundation News Section.